drugset / Trial / NCT02867722
Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Withdrawn
Brigham and Women's Hospital
NaSingle-groupOpen-labelTreatment
Summary
In this study, daylight PDT will be administered to interested patients at Dana-Farber/Brigham and Women's Cancer Center. Daylight PDT has been shown to be an effective and painless alternative to traditional PDT. Daylight PDT involves application of the photosensitizer in the physician's office followed by exposure to daylight.
Timeline
- Start
- 2020-12
- Primary completion
- 2021-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | — | Topical |